5-Formyl-4-methylthiophene-2-carboxylic acid → N-((S)-3-{2-Ethyl-4-[5-(5-formyl-4-methyl-thiophen-2-yl)-[1,2,4]oxadiazol-3-yl]-6-methyl-phenoxy}-2-hydroxy-propyl)-2-hydroxy-acetamide

Participants

Reaction Steps

The title compound is prepared according to Method A starting from 5-formyl-4-methyl-thiophene-2-carboxylic acid and N—((S)-3-[2-ethyl-4-(N-hydroxycarbamimidoyl)-6-methyl-phenoxy]-2-hydroxy-propyl)-2-hydroxy-acetamide; LC-MS: tR=0.92 min; [M+1]+=460.17; 1H NMR δ 1.22 (t, J=7.5 Hz, 3H), 2.35 (s, 3H), 2.65 (s, 3H), 2.73 (q, J=7.5 Hz, 2H), 3.20-3.28 (m, 1H), 3.39-3.47 (m, 1H), 3.70-3.80 (m, 2H), 3.84 (d, J=5.5 Hz, 2H), 3.92-4.00 (m, 1H), 5.30 (d, J=5.3 Hz, 1H), 5.54 (t, J=5.8 Hz, 1H), 7.69 (t, J=5.5 Hz, 1H), 7.76 (s, 2H), 8.07 (s, 1H), 10.17 (s, 1H).

Provenance & Evidence